» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing


More Information on Suvorexant

Letter to the FDA Opposing Approval of the Sleep Medicine Suvorexant

June 14, 2013

View as PDF.

This letter was sent to the U.S. Food and Drug Administration (FDA) as a follow-up to our testimony at the May 22, 2013 meeting of the Peripheral and Central Nervous System Drugs Advisory Committee that voted in favor of approval of the dangerous sleep medicine, suvorexant. We again urge the FDA not to approve suvorexant because the drug’s long-lasting risks – both to patients and the general public – outweigh any short-term benefits on sleep.

July 29, 2013, FDA Response to Letter

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.